awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37412018-14FA602B-25C8-4721-A15E-FA1D154C84DF
Q37412018-14FA602B-25C8-4721-A15E-FA1D154C84DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37412018-14FA602B-25C8-4721-A15E-FA1D154C84DF
Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells
P2860
Q37412018-14FA602B-25C8-4721-A15E-FA1D154C84DF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37412018-14FA602B-25C8-4721-A15E-FA1D154C84DF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
25afd738c6e876b3b3b82703ffe465e677512f6c
P2860
[Artesunate combined with vinorelbine plus cisplatin in treatment of advanced non-small cell lung cancer: a randomized controlled trial].